EUVIMEDOdkrijte EUVIMED
CrossrefInformacijska kartica

OT-CATH, a conserved antimicrobial peptide in Otariidae species, exhibits potent activity against gram-negative bacteria

Yixiao Song, Yufeng Ren, Juan Wang, Zifan Ye, Chenchen Shi, Xiangjin Kong, Xudong Jiao, Jingjing Zhang, Yipeng Wang

Antimicrobial Agents and Chemotherapy · 2026-11-04 · 70 (11)

DOI: 10.1128/aac.01026-26 ↗
PovzetekBibliografski podatki

Povzetek

ABSTRACT The rapid emergence of multidrug-resistant gram-negative bacteria necessitates the development of effective antimicrobial agents to combat antimicrobial resistance. Here, we identified and characterized OT-CATH, a conserved cathelicidin-family antimicrobial peptide derived from Otariidae species. OT-CATH exhibited potent bactericidal activity against gram-negative bacteria, particularly extended-spectrum β-lactamase-producing Escherichia coli , with rapid killing kinetics, potent antibiofilm activity, and no detectable resistance after 40 serial passages. Mechanistically, OT-CATH bound lipopolysaccharide, disrupted both the outer and inner bacterial membranes, and translocated into the cytoplasm to interact with bacterial DNA. Membrane disruption further triggered intracellular reactive oxygen species accumulation, proton motive force dissipation, ATP depletion, and metabolic collapse, collectively leading to bacterial death. OT-CATH also demonstrated favorable stability, low cytotoxicity, and favorable pharmacokinetic properties with measurable pulmonary distribution. In a murine pneumonia model, OT-CATH significantly improved survival, reduced bacterial burdens in the lungs and bronchoalveolar lavage fluid, and alleviated lung injury. These findings identify OT-CATH as a promising membrane-targeting antimicrobial peptide for the treatment of multidrug-resistant gram-negative bacterial infections.

Znanje, ki ustreza vašemu delu.

Od brezplačnega začetka in osebnega iskanja literature do celotnega paketa Research Suite.

Ogled tarif →

Ali so vključena vsa polna besedila založnikov?

Ne. Bibliografski zapisi, povzetki in celotna besedila so različne vsebine. Ali je celotno besedilo na voljo, je odvisno od vira, odprtega dostopa in vaših obstoječih licenc. Paket EUVIMED ne nadomešča dodatnih pravic založnikov.

Ogled tarif →